Provident Investment Management, Inc. Amgen Inc Transaction History

Provident Investment Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $228,314 - $261,284	-1,148 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$212.27 - $248.7 $243,685 - $285,507	1,148 New	1,148 $244,000
Q1 2020 May 04, 2020	SELL	$182.24 - $241.7 $218,688 - $290,040	-1,200 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $1.07 Million - $1.25 Million	-6,000 Reduced 83.33%	1,200 $234,000
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $1.11 Million - $1.25 Million	-6,000 Reduced 45.45%	7,200 $1.49 Million
Q2 2018 Aug 09, 2018	BUY	$166.05 - $186.51 $996,300 - $1.12 Million	6,000 Added 83.33%	13,200 $2.44 Million
Q1 2018 Apr 23, 2018	SELL	$169.43 - $198.0 $76,243 - $89,100	-450 Reduced 5.88%	7,200 $1.23 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $1.28 Million - $1.46 Million	7,650	7,650 $1.43 Million

3,054

409M

7.19M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Provident Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Provident Investment Management, Inc. with notifications on news.